Tag: patients

Evaxion receives Prix Galien UK Award for Best digital health solution

COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital health solution for AI-Immunology™.

EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden

Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases

Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseases

Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

HONG KONG, June 11, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) today announced that the National Medical Products Administration (NMPA) of China has approved gumokimab...

Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and...

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile —

/C O R R E C T I O N — Melanoma Research Alliance/

In the news release, LEVERAGED FINANCE FIGHTS MELANOMA RAISES RECORD $4.3 MILLION FOR THE MELANOMA RESEARCH ALLIANCE, issued 11-Jun-2026 by Melanoma Research Alliance over...

Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis

Hiding in Plain Sight: New Survey Exposes Awareness Gap Around the Second Most Common Type of Breast Cancer

ChronicleBio Is Coming for Chronic Disease: Pioneering Immunologist Joins Elite Scientific Team to Translate Biological Signal into Targeted Therapeutics

The Emerging Techbio Company Appoints Dr. John Mumm as CSO Alongside Head of Platform Dr. Yambazi Banda to Decode the Molecular Underpinnings of Neuroimmune...

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

Elutia presents at Planet MicroCap 2026, discussing its drug-eluting biomatrix technology targeting post-surgical infection in breast reconstruction.

ENSG Investor News: If You Have Suffered Losses in Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

MGB Home Hospital Clinicians Protest Outside Somerville Headquarters Seeking a Fair Contract to Protect Patients and Respect Staff

Clinicians negotiating a first MNA contract say Mass General Brigham is prioritizing growth and census numbers over patient and staff safety in the Home...

LifeLabs Recognized Once Again by Forbes as One of Canada’s Best Employers for 2026

Toronto, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce that we have been named as one of Canada’s Best Employers for 2026 by Forbes Canada.

Canada’s Largest Athletic Fundraiser Raises a Record $23.3 Million in Support of The Princess Margaret Cancer Foundation

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

Evaxion receives Prix Galien UK Award for Best digital health solution

EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden

Akeso’s Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio

Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress

/C O R R E C T I O N — Melanoma Research Alliance/

Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds

Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis

Hiding in Plain Sight: New Survey Exposes Awareness Gap Around the Second Most Common Type of Breast Cancer

ChronicleBio Is Coming for Chronic Disease: Pioneering Immunologist Joins Elite Scientific Team to Translate Biological Signal into Targeted Therapeutics

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

ENSG Investor News: If You Have Suffered Losses in Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About...

MGB Home Hospital Clinicians Protest Outside Somerville Headquarters Seeking a Fair Contract to Protect Patients and Respect Staff

LifeLabs Recognized Once Again by Forbes as One of Canada’s Best Employers for 2026

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us